Table 4:

Immune-related adverse events

Immune-related Adverse Events Characteristics (N=28)	N (%)
irAE
Yes	11 (39)
No	17 (60)
Grade
1	5 (18)
2	1 (3)
3	3 (11)
4	1 (3)
5	1(3)
Event
Colitis/Diarrhea	1(3)
Thyroiditis	1 (3)
Dermatitis	5 (18)
Musculoskeletal	2 (7)
Pneumonitis	1 (3)
Uveitis	1 (3)
Immunomodulatory therapy
Systemic	6 (21)
Local	3 (11)
Not needed	2 (7)
ICI Treatment Discontinuation	25 (89)
Reason for discontinuation
Toxicity	10 (36)
Disease progression	8 (28)
Other	7 (25)

Abbreviations: irAE; Immune-related Adverse Events, ICI; Immune Checkpoint inhibitors.